Shanghai Conant Optical Co Ltd
HKEX:2276
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (2.8), the stock would be worth HK$14.69 (69% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.1 | HK$47.64 |
0%
|
| 3-Year Average | 2.8 | HK$14.69 |
-69%
|
| 5-Year Average | 2.6 | HK$13.83 |
-71%
|
| Industry Average | 4.4 | HK$22.99 |
-52%
|
| Country Average | 2.8 | HK$14.44 |
-70%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
HK$22.5B
|
/ |
Jan 2026
¥2.2B
|
= |
|
|
HK$22.5B
|
/ |
Dec 2026
¥2.6B
|
= |
|
|
HK$22.5B
|
/ |
Dec 2027
¥3.2B
|
= |
|
|
HK$22.5B
|
/ |
Dec 2028
¥3.7B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
23.3B HKD | 9.1 | 35.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 10.7 | 39.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.2B CHF | 3.4 | 36.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
89.7B DKK | 3.2 | 22.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD | 3.1 | 30.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | 99.2 | -37.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 2.2 | 31.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38B CNY | 8.4 | 23 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.8B CNY | 3.8 | 22.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
875B JPY | 6.7 | 49.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Shanghai Conant Optical Co Ltd
Glance View
Shanghai Conant Optical Co., Ltd. engages in business of manufacturing and sale of resin spectacle lenses. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-16. The firm produces a variety of resin glasses, including standardized lenses and customized lenses. The firm's products are exported to the United States, Japan, India, Australia, Thailand, Germany, Brazil and other countries and regions.
